Revance Therapeutics
RVNC
#7076
Rank
NZ$0.66 B
Marketcap
$6.37
Share price
-2.86%
Change (1 day)
-47.40%
Change (1 year)

P/S ratio for Revance Therapeutics (RVNC)

P/S ratio as of November 2024 (TTM): 1.66

According to Revance Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -3.11. At the end of 2024 the company had a P/S ratio of 1.10.

P/S ratio history for Revance Therapeutics from 2014 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.10-67.14%
20233.35-70.77%
202211.5-23.93%
202115.1-87.76%
2020123-94.02%
2019> 1000930.89%
2018200-95.98%
2017> 1000152.17%
2016> 1000-38.92%
2015> 1000206.32%
2014> 1000

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
103 6,149.63%๐Ÿ‡บ๐Ÿ‡ธ USA
4.25 156.51%๐Ÿ‡บ๐Ÿ‡ธ USA
2.40 44.79%๐Ÿ‡บ๐Ÿ‡ธ USA